BlackRock, Inc. - Net Worth and Insider Trading
BlackRock, Inc. Net Worth
The estimated net worth of BlackRock, Inc. is at least $237 Million dollars as of 2024-09-29. BlackRock, Inc. is the 2201 Interest of corporation controlled by you of Hangzhou Tigermed Consulting Co Ltd and owns about 6,791,549 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) stock worth over $237 Million. Details can be seen in BlackRock, Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that BlackRock, Inc. has not made any transactions after 2023-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of BlackRock, Inc.
BlackRock, Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, BlackRock, Inc. owns 1 companies in total, including Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) .
Click here to see the complete history of BlackRock, Inc.’s form 4 insider trades.
Insider Ownership Summary of BlackRock, Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:03347 | Hangzhou Tigermed Consulting Co Ltd | 2023-08-15 | 2201 Interest of corporation controlled by you |
BlackRock, Inc. Latest Holdings Summary
BlackRock, Inc. currently owns a total of 1 stock. BlackRock, Inc. owns 6,791,549 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) as of August 15, 2023, with a value of $237 Million.
Latest Holdings of BlackRock, Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:03347 | Hangzhou Tigermed Consulting Co Ltd | 2023-08-15 | 6,791,549 | 34.95 | 237,364,638 |
Holding Weightings of BlackRock, Inc.
BlackRock, Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, BlackRock, Inc. has made a total of 254 transactions in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Hangzhou Tigermed Consulting Co Ltd is the sale of 0 shares on August 15, 2023, which brought BlackRock, Inc. around $0.
Insider Trading History of BlackRock, Inc.
- 1
BlackRock, Inc. Trading Performance
GuruFocus tracks the stock performance after each of BlackRock, Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by BlackRock, Inc. is -27.17%. GuruFocus also compares BlackRock, Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by BlackRock, Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how BlackRock, Inc.'s insider trading performs compared to the benchmark.
Performance of BlackRock, Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.94 | | | | | |
| Relative Return to S&P 500(%) | -30.41 | | | | | |
BlackRock, Inc. Ownership Network
BlackRock, Inc. Owned Company Details
What does Hangzhou Tigermed Consulting Co Ltd do?
Who are the key executives at Hangzhou Tigermed Consulting Co Ltd?
BlackRock, Inc. is the 2201 Interest of corporation controlled by you of Hangzhou Tigermed Consulting Co Ltd. Other key executives at Hangzhou Tigermed Consulting Co Ltd include 2102 Investment manager yi fang da ji jin guan li you xian gong si , 2101 Beneficial owner Sands Capital Management, LLC , and 2201 Interest of corporation controlled by you Sands Capital Management, LP .
Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) Insider Trades Summary
Over the past 18 months, BlackRock, Inc. made 54 insider transaction in Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) with a net purchase of 614,287. Other recent insider transactions involving Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) include a net sale of 470,919 shares made by Jpmorgan Chase & Co. , a net sale of 0 shares made by Citigroup Inc. , and a net sale of 0 shares made by Ubs Group Ag .
In summary, during the past 3 months, insiders sold 0 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,186,442 shares of Hangzhou Tigermed Consulting Co Ltd (HKSE:03347) were sold and 6,491,910 shares were bought by its insiders, resulting in a net purchase of 2,305,468 shares.
Hangzhou Tigermed Consulting Co Ltd (HKSE:03347)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hangzhou Tigermed Consulting Co Ltd Insider Transactions
BlackRock, Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for BlackRock, Inc.. Currently GuruFocus does not have mailing address information for BlackRock, Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
